Skip to main content
Clinical Trials/NCT02495675
NCT02495675
Unknown
Not Applicable

Effects of Treatment With High Flow Nasal Cannulas on Respiratory Pattern and Work of Breathing Among Healthy Subjects

Laval University1 site in 1 country10 target enrollmentJune 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiratory Failure
Sponsor
Laval University
Enrollment
10
Locations
1
Primary Endpoint
Work of breathing
Last Updated
10 years ago

Overview

Brief Summary

This study evaluates the work of breathing among healthy subjects under various conditions of treatment with high flow nasal cannulas. Ten subjects will be included. The design of this study is a cross over of five treatment periods with different flow settings.

Detailed Description

High flow oxygen therapy (HFOT) is a promising technique increasingly used in the management of acute respiratory failure. In hospitalised hypoxemic patients, recent clinical evidence showed that HFOT can reduce endotracheal intubation and reduce mortality. Physiologically, the HFOT causes a decrease in respiratory rate and minute-ventilation and may be associated with a decrease in carbone dioxyde arterial pressure. It is possible that these effects are associated with decreased work of breathing, which could explain some of the benefits in terms of comfort and efficiency. The objective of this research is to evaluate the impact of a wash-out of anatomical dead space by high flow nasal cannulas on respiratory parameters and on the work of breathing among healthy subjects. The investigators will evaluate the baseline status in room air, and then compare it with four different levels of flow. The primary endpoint will be the work of breathing.

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
October 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy subjects
  • Written and informed consent

Exclusion Criteria

  • Pregnant or breastfeeding women;
  • Subject enrolled in another study excluding co-enrolment;
  • Cardio-vascular or respiratory disease;
  • History of ear nose and throat disease (i.e. surgery, epistaxis, trauma), eso-gastric disease (i.e. esophageal varices, digestive haemorrhage), rheumatologic or neurologic disease possibly interfering with the design of the study;
  • Subject feeling nauseous or under recent fed condition (\<1h).

Outcomes

Primary Outcomes

Work of breathing

Time Frame: 10 minutes

Work of breathing at the end of each period is calculated from the measurement of esophageal pressure and tidal volume (composite outcome).

Secondary Outcomes

  • Blood gases(10 minutes)
  • Comfort of breathing(10 minutes)
  • Tidal Volume(10 minutes)
  • End-tidal carbon dioxide(10 minutes)
  • Oxygen saturation(10 minutes)
  • Dyspnea(10 minutes)
  • Respiratory Rate(10 minutes)
  • Esophageal pressure-time product(10 minutes)
  • Heart rate(10 minutes)

Study Sites (1)

Loading locations...

Similar Trials